The use of a 51Cr technique to detect gastrointestinal microbleeding associated with nonsteroidal antiinflammatory drugs

André Lussier, André Arsenault, John Varady, Rinaldo de Medicis, Yves A Lussier, Etienne LeBel

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Of techniques used to evaluate gastrointestinal (GI) bleeding, use of radiochromium (51Cr)-tagged erythrocytes is the most quantitative and scientifically acceptable method. The value of this technique as well as systematic errors possible with its use are discussed. The medical literature concerning 51Cr evaluation of GI microbleeding with naproxen therapy is critically reviewed. We suggest that future studies using this technique be parallel, randomized, double-blind, and include a 1-week placebo baseline phase for all subjects. Treatment with nonsteroidal antiinflammatory drugs (NSAIDs) should last 3 to 4 weeks. A parallel group of subjects should receive placebo throughout the study. For valid statistical analyses, randomization must achieve baseline comparability of weight, height, age, and sex in the treatment groups. Data transformations may be necessary to satisfy the assumptions of the statistical model. Following these guidelines will enable investigators to better evaluate GI microbleeding during treatment with naproxen or other NSAIDs, and, hopefully, to establish the safety profiles of these drugs.

Original languageEnglish (US)
Pages (from-to)40-45
Number of pages6
JournalSeminars in Arthritis and Rheumatism
Volume17
Issue number3 SUPPL. 2
DOIs
StatePublished - 1988
Externally publishedYes

Fingerprint

Anti-Inflammatory Agents
Naproxen
Pharmaceutical Preparations
Placebos
Statistical Models
Therapeutics
Random Allocation
Erythrocytes
Research Personnel
Guidelines
Hemorrhage
Safety
Weights and Measures

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Orthopedics and Sports Medicine
  • Rheumatology

Cite this

The use of a 51Cr technique to detect gastrointestinal microbleeding associated with nonsteroidal antiinflammatory drugs. / Lussier, André; Arsenault, André; Varady, John; de Medicis, Rinaldo; Lussier, Yves A; LeBel, Etienne.

In: Seminars in Arthritis and Rheumatism, Vol. 17, No. 3 SUPPL. 2, 1988, p. 40-45.

Research output: Contribution to journalArticle

Lussier, André ; Arsenault, André ; Varady, John ; de Medicis, Rinaldo ; Lussier, Yves A ; LeBel, Etienne. / The use of a 51Cr technique to detect gastrointestinal microbleeding associated with nonsteroidal antiinflammatory drugs. In: Seminars in Arthritis and Rheumatism. 1988 ; Vol. 17, No. 3 SUPPL. 2. pp. 40-45.
@article{5fa9e7ea512a4aa5a66aea679b42dc93,
title = "The use of a 51Cr technique to detect gastrointestinal microbleeding associated with nonsteroidal antiinflammatory drugs",
abstract = "Of techniques used to evaluate gastrointestinal (GI) bleeding, use of radiochromium (51Cr)-tagged erythrocytes is the most quantitative and scientifically acceptable method. The value of this technique as well as systematic errors possible with its use are discussed. The medical literature concerning 51Cr evaluation of GI microbleeding with naproxen therapy is critically reviewed. We suggest that future studies using this technique be parallel, randomized, double-blind, and include a 1-week placebo baseline phase for all subjects. Treatment with nonsteroidal antiinflammatory drugs (NSAIDs) should last 3 to 4 weeks. A parallel group of subjects should receive placebo throughout the study. For valid statistical analyses, randomization must achieve baseline comparability of weight, height, age, and sex in the treatment groups. Data transformations may be necessary to satisfy the assumptions of the statistical model. Following these guidelines will enable investigators to better evaluate GI microbleeding during treatment with naproxen or other NSAIDs, and, hopefully, to establish the safety profiles of these drugs.",
author = "Andr{\'e} Lussier and Andr{\'e} Arsenault and John Varady and {de Medicis}, Rinaldo and Lussier, {Yves A} and Etienne LeBel",
year = "1988",
doi = "10.1016/0049-0172(88)90044-3",
language = "English (US)",
volume = "17",
pages = "40--45",
journal = "Seminars in Arthritis and Rheumatism",
issn = "0049-0172",
publisher = "W.B. Saunders Ltd",
number = "3 SUPPL. 2",

}

TY - JOUR

T1 - The use of a 51Cr technique to detect gastrointestinal microbleeding associated with nonsteroidal antiinflammatory drugs

AU - Lussier, André

AU - Arsenault, André

AU - Varady, John

AU - de Medicis, Rinaldo

AU - Lussier, Yves A

AU - LeBel, Etienne

PY - 1988

Y1 - 1988

N2 - Of techniques used to evaluate gastrointestinal (GI) bleeding, use of radiochromium (51Cr)-tagged erythrocytes is the most quantitative and scientifically acceptable method. The value of this technique as well as systematic errors possible with its use are discussed. The medical literature concerning 51Cr evaluation of GI microbleeding with naproxen therapy is critically reviewed. We suggest that future studies using this technique be parallel, randomized, double-blind, and include a 1-week placebo baseline phase for all subjects. Treatment with nonsteroidal antiinflammatory drugs (NSAIDs) should last 3 to 4 weeks. A parallel group of subjects should receive placebo throughout the study. For valid statistical analyses, randomization must achieve baseline comparability of weight, height, age, and sex in the treatment groups. Data transformations may be necessary to satisfy the assumptions of the statistical model. Following these guidelines will enable investigators to better evaluate GI microbleeding during treatment with naproxen or other NSAIDs, and, hopefully, to establish the safety profiles of these drugs.

AB - Of techniques used to evaluate gastrointestinal (GI) bleeding, use of radiochromium (51Cr)-tagged erythrocytes is the most quantitative and scientifically acceptable method. The value of this technique as well as systematic errors possible with its use are discussed. The medical literature concerning 51Cr evaluation of GI microbleeding with naproxen therapy is critically reviewed. We suggest that future studies using this technique be parallel, randomized, double-blind, and include a 1-week placebo baseline phase for all subjects. Treatment with nonsteroidal antiinflammatory drugs (NSAIDs) should last 3 to 4 weeks. A parallel group of subjects should receive placebo throughout the study. For valid statistical analyses, randomization must achieve baseline comparability of weight, height, age, and sex in the treatment groups. Data transformations may be necessary to satisfy the assumptions of the statistical model. Following these guidelines will enable investigators to better evaluate GI microbleeding during treatment with naproxen or other NSAIDs, and, hopefully, to establish the safety profiles of these drugs.

UR - http://www.scopus.com/inward/record.url?scp=0023934440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023934440&partnerID=8YFLogxK

U2 - 10.1016/0049-0172(88)90044-3

DO - 10.1016/0049-0172(88)90044-3

M3 - Article

VL - 17

SP - 40

EP - 45

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

SN - 0049-0172

IS - 3 SUPPL. 2

ER -